LECANEMAB RECEIVES PRIORITY REVIEW STATUS IN JAPAN
Go back to LECANEMAB RECEIVES PRIORITY REVIEW STATUS IN JAPAN| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 184.87 -3.21 (1.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $188.08 | 52 Week High | $333.65 | |||
| Open | $186.25 | 52 Week Low | $223.02 | |||
| Day High | $186.25 | P/E | 23.67 | |||
| Day Low | $181.24 | EPS | $7.81 | |||
| Volume | 772,902 | |||||
| Eisai Co Ltd American Depositary Shares (AMEX: ESALY) | Delayed: 61.51 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $61.51 | 52 Week High | $67.60 | |||
| Open | $49.73 | 52 Week Low | $53.55 | |||
| Day High | $61.51 | P/E | N/A | |||
| Day Low | $61.51 | EPS | $0.00 | |||
| Volume | 1,907,007 | |||||
